Detection & Diagnostics

Insights that can improve response readiness and public health

Tools for a Fast Response

MRIGlobal has decades of experience developing, optimizing, and evaluating technologies to identify pathogens, biomarkers, and other clinically relevant targets. Our expertise includes targeted and agnostic detection approaches, including next-generation sequencing (NGS), which can include comprehensive characterization of known, emerging, and previously unrecognized biological agents. These capabilities support disease detection, outbreak investigations, patient monitoring, biosurveillance, and regulatory-compliant diagnostic performance. By integrating advanced molecular diagnostics, sequencing technologies, and analytical expertise, MRIGlobal helps accelerate product development, reduce technical and regulatory risk, and deliver IVD and RUO solutions.

Enabling Rapid Pathogen Detection and Response

Identify bacterial, viral, and fungal pathogens using molecular and other laboratory-based methods.

Develop PCR-based multiplex panels and molecular platforms to enable rapid, sensitive pathogen detection.

Perform sequencing with optimized workflows, such as direct pathogen detection from complex samples.

Test and evaluate diagnostic tests in both clinical and laboratory environments according to regulatory requirements.

Detect infectious agents in water, air, and surface samples for public health monitoring.

Latest from the blog

MRIGlobal Expert

Get in Touch

Welcome to the new MRIGlobal site. Built to carry our mission forward. Discover what's new!

X